Suzhou Kintor Pharma raised $44M in a funding led by Shenzhen Green Pine Capital Partners.
January 12, 2018 -- Suzhou Kintor Pharma raised $44 million in a funding led by Shenzhen Green Pine Capital Partners. Established in 2009, Kintor is an innovative high-tech pharma developing novel products. Since its founding, the company has received over 25 Significant New Drug Creation awards, plus the China Science and Technology Ministry’s small and mid-size enterprise innovation funding support along with other awards.
